These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8099506)

  • 1. Immunohistology and immunocytology of human T-cell chimerism and graft-versus-host disease in SCID mice.
    Hoffmann-Fezer G; Gall C; Zengerle U; Kranz B; Thierfelder S
    Blood; 1993 Jun; 81(12):3440-8. PubMed ID: 8099506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4-CD8-C.B-17 SCID thymocytes enter the CD4+CD8+ stage in the presence of neonatally grafted T cells.
    Schneider MK; Grönvik KO
    Scand J Immunol; 1998 May; 47(5):466-74. PubMed ID: 9627131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal sanctuary for human lymphopoiesis in SCID mice injected with human peripheral blood lymphocytes from Epstein-Barr virus-negative donors.
    Hoffmann-Fezer G; Kranz B; Gall C; Thierfelder S
    Eur J Immunol; 1992 Dec; 22(12):3161-6. PubMed ID: 1359971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD3+ T cells in severe combined immunodeficiency (scid) mice. II. Transplantation of dm2 lymphoid cells into semi-allogeneic scid mice.
    Rudolphi A; Spiess S; Conradt P; Claesson MH; Reimann J
    Eur J Immunol; 1991 Jul; 21(7):1591-600. PubMed ID: 1829409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras.
    Tary-Lehmann M; Lehmann PV; Schols D; Roncarolo MG; Saxon A
    J Exp Med; 1994 Nov; 180(5):1817-27. PubMed ID: 7964463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
    Xun CQ; Thompson JS; Jennings CD; Brown SA
    Transplantation; 1995 Oct; 60(8):821-7. PubMed ID: 7482742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine A effectively inhibits graft-versus-host disease during development of Epstein-Barr virus-infected human B cell lymphoma in SCID mouse.
    Gan R; Yin Z; Liu T; Wang L; Tang Y; Song Y
    Cancer Sci; 2003 Sep; 94(9):796-801. PubMed ID: 12967478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of primary antigen-specific human cytotoxic T lymphocytes in human/mouse radiation chimera.
    Segall H; Lubin I; Marcus H; Canaan A; Reisner Y
    Blood; 1996 Jul; 88(2):721-30. PubMed ID: 8695821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood.
    Tary-Lehmann M; Saxon A
    J Exp Med; 1992 Feb; 175(2):503-16. PubMed ID: 1346272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat stem cells developing in irradiated SCID mice fail to become tolerized and cause lethal graft-versus-host disease.
    Surh CD; Kosaka H; Sprent J
    Am J Pathol; 1997 Aug; 151(2):591-9. PubMed ID: 9250172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-species graft-versus-host-disease is accompanied by a donor-derived cellular immune response.
    Cooper MH; Nalesnik MA; Watkins SC; Hoffman RA; Ildstad ST
    Transplantation; 1993 Oct; 56(4):934-40. PubMed ID: 8212220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation.
    Truitt RL; Atasoylu AA
    Blood; 1991 Jun; 77(11):2515-23. PubMed ID: 2039833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells.
    Sefrioui H; Billiau AD; Overbergh L; Rutgeerts O; Waer M
    Transplantation; 1999 Nov; 68(10):1560-7. PubMed ID: 10589955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
    Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
    J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood.
    Gorin NC; Piantadosi S; Stull M; Bonte H; Wingard JR; Civin C
    J Hematother Stem Cell Res; 2002 Apr; 11(2):277-92. PubMed ID: 11983099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD3+ T cells in severe combined immunodeficiency (SCID) mice. V. Allogeneic T cells engrafted into SCID mice do not induce graft-versus-host disease in spite of the absence of host veto and natural suppressor cell activity.
    Tscherning T; Rudolphi A; Reimann J; Claesson MH
    Scand J Immunol; 1991 Dec; 34(6):795-801. PubMed ID: 1836277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features].
    Liang ZX; Cheng Q; Chen HZ; Xie X; Ye DF
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1465-9. PubMed ID: 15500747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloimmune injury and rejection of human skin grafts on human peripheral blood lymphocyte-reconstituted non-obese diabetic severe combined immunodeficient beta2-microglobulin-null mice.
    Turgeon NA; Banuelos SJ; Shultz LD; Lyons BL; Iwakoshi N; Greiner DL; Mordes JP; Rossini AA; Appel MC
    Exp Biol Med (Maywood); 2003 Oct; 228(9):1096-104. PubMed ID: 14530522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.